site stats

Brisken cathrin

WebCathrin Brisken, MD, PhD, is internationally recognized for her research on the influence of hormones on breast development and the development … WebAU - Brisken, Cathrin. AU - Carroll, Jason S. PY - 2024/9/14. Y1 - 2024/9/14. N2 - The cytokine interleukin-6 (IL6) and its downstream effector STAT3 constitute a key oncogenic pathway, which has been thought to be functionally connected to estrogen receptor α (ER) in breast cancer. We demonstrate that IL6/STAT3 signaling drives metastasis in ...

The tumor cell‐derived matrix of lobular breast cancer: a new …

WebCorrespondence: cathrin.brisken@epfl.ch Awoman’s breast cancer risk is affected by her reproductive history. The hormonal milieu also influences the course of the disease. The female ... WebFeb 22, 2024 · New findings from Cathrin Brisken and collea-gues have added another arrow to the quiver. While broad-spectrum lysyl oxidase inhibitors like BAPN are too toxic for clinical application, other more specific approaches to target LOXL1 could be developed and combined with any of the above therapies. ILC has never received the attention that it ... office foot warmer pad https://roywalker.org

Progesterone signalling in breast cancer: a neglected hormone …

WebCathrin Brisken. Unknown affiliation. Verified email at epfl.ch. Articles Cited by Public access. Title. Sort. Sort by citations Sort by year Sort by title. Cited by. Cited by. ... C Brisken, S Kaur, TE Chavarria, N Binart, RL Sutherland, RA Weinberg, ... Developmental biology 210 (1), 96-106, 1999. 432: WebCathrin Brisken. Unknown affiliation. Verified email at epfl.ch. Articles Cited by Public access. Title. Sort. Sort by citations Sort by year Sort by title. Cited by. Cited by. ... C … WebFeb 22, 2024 · This month's cover highlights the article Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1 by George Sflomos, Cathrin Brisken and colleagues. Whole mount micrographs of mouse mammary glands intraductally engrafted with lobular breast cancer cells and stained with carmine … myclosing

Cathrin Brisken - Wikiwand

Category:Abstract - American Association for Cancer Research

Tags:Brisken cathrin

Brisken cathrin

Cathrin Brisken Science Lab Leica Microsystems

WebAU - Brisken, Cathrin. AU - Minucci, Saverio. AU - Di Fiore, Pier Paolo. AU - Pelicci, Pier Giuseppe. PY - 2009/9/18. Y1 - 2009/9/18. N2 - Stem-like cells may be integral to the development and maintenance of human cancers. Direct proof is still lacking, mainly because of our poor understanding of the biological differences between normal and ... WebE-mail address: cathrin.brisken@epfl.ch (C. Brisken). Molecular and Cellular Endocrinology xxx (2011) xxx–xxx Contents lists available at SciVerse ScienceDirect Molecular and Cellular Endocrinology

Brisken cathrin

Did you know?

WebCathrin Brisken, MD, PhD, is Associate Professor of Life Sciences at the Swiss Federal Institute of Technology Lausanne (EPFL). Dr. Brisken is internationally recognized for … WebCathrin Brisken, MD, PhD, is internationally recognized for her spearheading research on the influence of hormones on breast development and the development of cancer …

WebProfessor Cathrin Brisken leads the Endocrine Control Mechanisms Team. Her research aims to understand how recurrent exposures to hormones contribute to breast cancer in order to better prevent and treat the … WebHead of laboratory : Prof. Cathrin Brisken. Office: SV 2832. Phone : +41 21 693 0781

WebCathrin Brisken, MD, PhD, is Associate Professor of Life Sciences at the Swiss Federal Institute of Technology Lausanne (EPFL). Dr. Brisken is internationally recognized for her work on endocrine control of mammary … WebInfo. Cathrin Brisken is internationally recognized for her work on endocrine control of mammary gland development and breast carcinogenesis. Dr. Brisken received her MD …

WebAtlas of Lobular Breast Cancer Models: Challenges and Strategic Directions. Cancers (basel), Vol.13 (21). show abstract. Brisken, C. Scabia, V. (2024). 90 YEARS OF PROGESTERONE: Progesterone receptor signaling in the normal breast and its implications for cancer. Journal of molecular endocrinology, Vol.65 (1), pp. T81-T94. …

WebOct 1, 2015 · Cathrin Brisken 1 Swiss Institute for Experimental Cancer Research (C.B., R.J.), Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland * Address all correspondence and requests for reprints to: Cathrin Brisken, Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique … office foot warmerWebJan 23, 2015 · Correspondence to: [email protected] Search for more papers by this author. Dalya Ataca. ISREC – Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. Search for more papers by this author. office foot stoolWebCathrin Brisken (born in 1967 in Osnabrück, Germany) is a german and swiss medical doctor, researcher, and professor at the École Polytechnique Fédérale de Lausanne … my closet spWebJan 23, 2015 · Cathrin Brisken. ISREC – Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. Correspondence to: [email protected] Search for more papers by this author office foot rest stoolWebCathrin Brisken. Invasive lobular carcinoma (ILC) accounts for up to 15% of all breast cancer (BC) cases and responds well to endocrine treatment when estrogen receptor α-positive … myclosing weissmanoffice for ageing well grantsWebAug 23, 2010 · Correspondence: cathrin.brisken@epfl.ch Awoman’s breast cancer risk is affected by her reproductive history. The hormonal milieu also influences the course of the disease. The female reproductive hormones, estrogens, progesterone, and prolactin, have a major impact on breast cancer and control postnatal mammary gland development. office for advancement of telehealth